Trial of Cell Based Therapy for DMD

Recruiting

Phase 1

Trial of Cell Based Therapy for DMDTrial of Cell Based Therapy for DMD

Sponsor:

Masonic Cancer Center, University of Minnesota

Code:

NCT06692426

Conditions

Duchenne Muscular Dystrophy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MyoPAXon

Tacrolimus

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by Masonic Cancer Center, University of Minnesota on 2025-03-25.